Pilot Study of Biomarker Modulation with a COX-2 Inhibitor using Ductal Lavage in Women at Increased Risk for Breast Cancer
Latest Information Update: 15 May 2013
At a glance
- Drugs Celecoxib (Primary)
- Indications Breast cancer
- Focus Biomarker; Pharmacodynamics
- 15 May 2013 New trial record